Development of adenopathy during the use of topical imiquimod

Journal of the American Academy of Dermatology

Volumn 64, Issue 5, 2011, Pages

  Anadkat, Milan J ^a   Bogucki, Benjamin A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; IMIQUIMOD; METHOTREXATE; RITUXIMAB; VINCRISTINE;

ADULT; APPLICATION SITE IRRITATION; BURKITT LYMPHOMA; CASE REPORT; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; INGUINAL LYMPH NODE; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; SUPPLEMENTATION;

EID: 79954609849     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.06.005     Document Type: Article

References (3)

1. P. Saiag, A. Bauhofer, F. Bouscarat, C. Aquilina, J.P. Ortonne, and N. Dupin Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study Br J Dermatol 161 2009 904 909
2. M.L. Diamantis, B.L. Bartlett, and S.K. Tyring Safety, efficacy and recurrence rates of imiquimod cream 5% for treatment of anogenital warts Skin Therapy Lett 14 2009 1 3 5
3. A.J. Wagstaff, and C.M. Perry Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions Drugs 67 2007 2187 2210 (Pubitemid 47557094)